API
< Back to all clusters
[BUSINESS] · United States · 3 sources

started · updated

Alzchem Group AG approves US nitroguanidine plant expansion

Alzchem Group AG has received approval from its supervisory board to proceed with the planning of a nitroguanidine production facility at its Bushy Park site in the United States. The company has been given the green light to order specific long-lead equipment components for the project.

The investment is estimated at approximately USD 150 million. The project is intended to strengthen Alzchem's position as a strategic supplier to the US defense industry by ensuring the supply of nitroguanidine to the US military.

Funding for the project will primarily be provided through a USD 150 million non-repayable investment grant from the US Department of Defense, supplemented by smaller amounts of support from state and county levels. This funding structure allows the company to expand production capacity without significantly impacting its own liquidity.

Entities

AlzChem Group AG · Bushy Park · US Department of Defense